Tutor information
Rebecca Ashfield
CSO, Ducentis Biotherapeutics Ltd
Rebecca Ashfield gained a first degree in Biochemistry and DPhil in molecular biology, both from the University of Oxford.
Dr Ashfield worked for 12 years at Immunocore Ltd, a biotechnology company making protein therapeutics for cancer immunotherapy, and joined the Jenner Institute in 2013 as a senior project manager for pre-clinical malaria, working with Professor Adrian Hill. She is now the CSO of Ducentis Biotherapeutics Ltd.
Courses
An overview of pre-clinical testing and pathway from pre-clinical testing to field trials, discussions of vaccine immunogenicity, phases of vaccine testing from Phase I to IV, and the development and manufacturing of vaccines with our expert presenters.